Carvedilol Impurity 14 | CAS 1198090-71-9 - Request Quote
Carvedilol Impurity 14
| SZ CAT No: | SZ-C014051 |
| CAS No | 1198090-71-9 |
| Mol.F. | C18H17NO3 |
| Mol.Wt. | 295.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Carvedilol Impurity 14 is chemically 4-(Oxiran-2-ylmethoxy)-9-(oxiran-2-ylmethyl)-9H-carbazole. Carvedilol Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Carvedilol Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Carvedilol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1198090-71-9
Purchase 1198090-71-9
Order 1198090-71-9
Enquire 1198090-71-9
price of 1198090-71-9
1198090-71-9 Supplier
1198090-71-9 Manufacturer
1198090-71-9 Exporter
buy high quality Carvedilol Impurity 14
Purchase Carvedilol Impurity 14
Carvedilol Impurity 14 suppliers
Carvedilol Impurity 14 manufacturers
Carvedilol Impurity 14 price
Order Carvedilol Impurity 14
Enquire Carvedilol Impurity 14
Carvedilol Impurity 14 cost
Carvedilol Impurity 14 Supplier
Carvedilol Impurity 14 Distributor
Carvedilol Impurity 14 for Method Validation
Carvedilol Reference Standard
Carvedilol Impurity 14 for ANDA Filing
Carvedilol Impurity 14 for Forced Degradation Studies
Carvedilol Impurity 14 Identification Standards
Carvedilol Impurity 14 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


